Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03979391
Other study ID # RC-P0070
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 26, 2019
Est. completion date November 26, 2024

Study information

Verified date September 2023
Source Lille Catholic University
Contact Lebitasy Marie Paule, PhD
Phone 03.20.22.57.41
Email Lebitasy.Marie-Paule@ghicl.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.


Description:

Multiple Sclerosis (MS) is a disease that affects the white matter of the central nervous system. In France, approximately 100,000 patients are affected. It is one of the most common neurological condition in young adults. The presence of supernumerary oligoclonal bands (OCBs) in the cerebrospinal fluid (CSF) in comparison to the serum was established in 2017 as a criterion for temporal dissemination in MS patients. This is a predictive factor of conversion to MS in the clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS), either in children or adults. However, the main inconvenient of OCB analysis in CSF is the requirement of a lumbar puncture, which is a traumatising technique that may raise ethical concerns especially when it has to be performed in children. Searching for OCBs in tears, which are more accessible, may represent an attractive alternative. Some published articles studying adult populations go in this direction, but there are no data in the literature regarding children. The main gold of this study is to lead a multicentric, prospective study, to evaluate the diagnostic quality of tears in children with clinically isolated syndrome (CIS) and radiologically isolated syndrome (RIS) during a longitudinal follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date November 26, 2024
Est. primary completion date November 26, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - age < 18 years old - informed consent from the child and the parents (at least one of the two legal guardians) - child covered by social security For the RIS population: - asymptomatic child - fortuitous discovery of lesions strongly suggesting sclerosis multiple on a Magnetic resonance imaging (MRI) scan For the CIS population: - child presenting a CIS in the past three months Exclusion Criteria: - patient with remitting MS - patient with progressive MS - patient with eye infection - patient under immunosuppressive therapy on the day of inclusion due to the treatment of another disease than MS

Study Design


Intervention

Diagnostic Test:
Tear collection and lumbar punction
Tear collection and lumbar punction will be performed in order to detect supernumerary oligoclonal bands

Locations

Country Name City State
France GHICL Lomme

Sponsors (1)

Lead Sponsor Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis Day 0
Primary Specificity of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis Day 0
Primary Positive predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis Day 0
Primary Negative predictive value of tears analysis compared to lumbar punction analysis for the diagnosis of CIS and RIS To evaluate the diagnostic performance of tears analysis in children with CIS and RIS, (sensitivity, specificity, positive and negative predictive value) being the gold standard the cerebrospinal analysis Day 0
Secondary Proportion of patients with OCBs in tears day 0, one year
See also
  Status Clinical Trial Phase
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Completed NCT02549703 - Mitochondrial Dysfunction and Disease Progression
Recruiting NCT03541226 - Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
Active, not recruiting NCT04998851 - A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab Phase 4
Recruiting NCT05277740 - Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
Recruiting NCT03004079 - Clinical Importance of Glucose Regulation in Relapsing MS
Completed NCT02043964 - Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion N/A
Completed NCT00287079 - A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated Syndrome Phase 3
Terminated NCT04599023 - Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System
Completed NCT01728922 - Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome Phase 1/Phase 2
Completed NCT01737372 - A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis N/A
Terminated NCT00595920 - Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Phase 2
Recruiting NCT05204459 - MS-ResearchBiomarkerS
Completed NCT04705610 - Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography N/A
Recruiting NCT03610139 - Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients N/A
Active, not recruiting NCT04009005 - Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis N/A
Not yet recruiting NCT06280755 - Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Completed NCT03872583 - Understanding Magnetic Resonance Imaging in Multiple Sclerosis N/A
Not yet recruiting NCT06274671 - Glymphatic MRI in Clinically Isolated Syndrome
Terminated NCT00819897 - Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta N/A